![\"2213566122_66c48070db_o\"](\"https:\/\/www.chameleon-pharma.com\/wp-content\/uploads\/2014\/07\/2213566122_66c48070db_o.jpg\")
<\/a> China-7571 – Sun and Moon Towers<\/a> von Dennis Jarvis <\/a> unter CC<\/a><\/p><\/div>\n China has estab\u00adlished an impres\u00adsive Health\u00adcare indus\u00adtry struc\u00adture, becom\u00ading one of the largest OTC and Pharma pro\u00adduc\u00aders in the world.<\/strong> The Chinese OTC and Pharma mar\u00adket has grown rapidly over the past ten years in the wake of the country\u2019s economic growth\u2014this is the main draw for Pharma investors with their sights set on China.<\/p>\n With a total mar\u00adket value of US $82.2 billion, the Chi\u00adnese phar\u00adma\u00adceu\u00adti\u00adcal mar\u00adket is dom\u00adi\u00adnated by orig\u00adi\u00adnal pre\u00adscrip\u00adtion drugs.<\/p>\n China has a regional mar\u00adket dis\u00adtri\u00adb\u00adu\u00adtion sys\u00adtem, and its main cus\u00adtomers are hos\u00adpi\u00adtals (56%), phar\u00adma\u00adcies (24%) and local health cen\u00adtres (20%). Domes\u00adtic demand for tra\u00addi\u00adtional Chi\u00adnese med\u00adi\u00adcines has fallen in recent years, with ris\u00ading levels of edu\u00adca\u00adtion and fre\u00adquency of chronic dis\u00adease. The \u2018busy lifestyle\u2019 is shift\u00ading the population\u2019s pref\u00ader\u00adence from herbal supplements to chem\u00adi\u00adcal drugs, but these traditional med\u00adica\u00adtions still occupy a sig\u00adnif\u00adi\u00adcant place in the OTC mar\u00adket. Cold and flu med\u00adi\u00adcines account for the high\u00adest demand in the OTC seg\u00adment, while dia\u00adbetes, hyper\u00adten\u00adsion and heart dis\u00adease drugs drive the demand in the pre\u00adscrip\u00adtion drugs seg\u00adment.<\/p>\n Imported phar\u00adma\u00adceu\u00adti\u00adcals for human use must have already obtained mar\u00adket approval in the coun\u00adtry where they are manufactured and must undergo clin\u00adi\u00adcal test\u00ading and registration in China.<\/p>\n In terms of cur\u00adrent dis\u00adtri\u00adb\u00adu\u00adtion issues, hos\u00adpi\u00adtals remain the dom\u00adi\u00adnant sales chan\u00adnel for phar\u00adma\u00adceu\u00adti\u00adcal drugs, account\u00ading for 70%, while retail phar\u00adma\u00adcies com\u00adprise the remain\u00adder. There are an esti\u00admated 360,000 drug retail\u00aders in urban China, with around 2,000 retail phar\u00admacy chains that oper\u00adate 120,000 stores; two of every three retail phar\u00adma\u00adcies are sole traders.<\/p>\n Four pre\u00advail\u00ading fac\u00adtors have con\u00adtributed to the chang\u00ading land\u00adscape of the phar\u00adma\u00adceu\u00adti\u00adcal mar\u00adket in China, mak\u00ading it the region to watch: urban\u00adi\u00adsa\u00adtion, an age\u00ading pop\u00adu\u00adlation, a lack of pri\u00admary care and a lack of pri\u00advate insur\u00adance.<\/p>\n Cur\u00adrently, how\u00adever, the Chi\u00adnese phar\u00adma\u00adceu\u00adti\u00adcal indus\u00adtry is focus\u00ading on generic prod\u00aducts. There is a great need for inno\u00adv\u00ada\u00adtive and pro\u00adpri\u00adetary prod\u00aducts in China that\u00a0will address the country\u2019s vast med\u00adical needs.<\/p>\n China and India: Big opportunities\u2026 or big risks?<\/strong><\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ admin_label=\u00bbHeader\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbRGBA(255,255,255,0)\u00bb background_image=\u00bbhttps:\/\/www.chameleon-pharma.com\/wp-content\/uploads\/bady-abbas-c4XoMGxfsVU-unsplash-scaled.jpg\u00bb background_blend=\u00bbcolor\u00bb height=\u00bb200px\u00bb max_height=\u00bb200px\u00bb custom_margin=\u00bb-15px||||false|false\u00bb custom_padding=\u00bb||||false|false\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row make_equal=\u00bbon\u00bb custom_padding_last_edited=\u00bbon|tablet\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb||||false|false\u00bb custom_padding_tablet=\u00bb0px||0px||true|false\u00bb custom_padding_phone=\u00bb0px||0px||true|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb custom_css_main_element=\u00bbmargin: auto;\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb header_font=\u00bb|700|||||||\u00bb header_text_color=\u00bb#FFFFFF\u00bb header_font_size=\u00bb45px\u00bb header_font_size_tablet=\u00bb45px\u00bb header_font_size_phone=\u00bb35px\u00bb header_font_size_last_edited=\u00bbon|phone\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ admin_label=\u00bbImage left, text right\u00bb _builder_version=\u00bb4.16″ custom_padding=\u00bb0|0px|0px|0px|false|false\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row column_structure=\u00bb1_2,1_2″ use_custom_gutter=\u00bbon\u00bb custom_padding_last_edited=\u00bbon|tablet\u00bb padding_top_bottom_link_2=\u00bbtrue\u00bb padding_left_right_link_2=\u00bbfalse\u00bb _builder_version=\u00bb4.16″ width=\u00bb100%\u00bb width_tablet=\u00bb80%\u00bb width_phone=\u00bb80%\u00bb width_last_edited=\u00bbon|tablet\u00bb max_width=\u00bb100%\u00bb max_width_tablet=\u00bb80%\u00bb max_width_phone=\u00bb80%\u00bb max_width_last_edited=\u00bbon|tablet\u00bb module_alignment=\u00bbleft\u00bb min_height=\u00bb681.3px\u00bb custom_margin=\u00bb|auto|-198px|auto|false|\u00bb custom_padding=\u00bb0|9.4%|149px|0px|false|false\u00bb custom_padding_tablet=\u00bb|0%||\u00bb custom_padding_phone=\u00bb\u00bb module_alignment_tablet=\u00bbcenter\u00bb module_alignment_phone=\u00bbcenter\u00bb module_alignment_last_edited=\u00bbon|tablet\u00bb use_custom_width=\u00bbon\u00bb width_unit=\u00bboff\u00bb custom_width_percent=\u00bb100%\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.16″ custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_image src=\u00bbhttps:\/\/www.chameleon-pharma.com\/wp-content\/uploads\/hanson-lu-_8EFj6ISA08-unsplash-1-scaled.jpg\u00bb alt=\u00bbAutumnal view of the chinese wall\u00bb title_text=\u00bbChinese Wall\u00bb show_bottom_space=\u00bboff\u00bb force_fullwidth=\u00bbon\u00bb align_tablet=\u00bbcenter\u00bb align_phone=\u00bbcenter\u00bb align_last_edited=\u00bbon|desktop\u00bb _builder_version=\u00bb4.16″ background_color_gradient_direction=\u00bb90deg\u00bb background_color_gradient_start=\u00bb#404451″ background_color_gradient_end=\u00bbrgba(240,242,246,0)\u00bb custom_padding=\u00bb||||false|false\u00bb custom_padding_tablet=\u00bb||60px|\u00bb custom_padding_phone=\u00bb||10px||false|false\u00bb custom_padding_last_edited=\u00bbon|phone\u00bb animation_style=\u00bbslide\u00bb animation_direction=\u00bbleft\u00bb animation_intensity_slide=\u00bb1%\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb text_font_size=\u00bb13px\u00bb custom_padding=\u00bb|||61px||\u00bb global_colors_info=\u00bb{}\u00bb]Featured image: Photo by Hanson Lu<\/a> on Unsplash<\/a>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.16″ custom_padding=\u00bb6vw||6vw|\u00bb custom_padding_tablet=\u00bb0px|0px|0px|0px|false|true\u00bb custom_padding_phone=\u00bb||||false|false\u00bb custom_padding_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb padding_phone=\u00bb||||false|false\u00bb padding_tablet=\u00bb|10%||10%|false|true\u00bb padding_last_edited=\u00bbon|tablet\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.17.4″ text_font=\u00bb||||||||\u00bb header_font=\u00bb||||||||\u00bb header_3_text_color=\u00bb#3550a0″ header_6_font=\u00bb||||||||\u00bb max_width=\u00bb917px\u00bb custom_margin=\u00bb-93px|-166px||||\u00bb custom_padding=\u00bb0px|||||\u00bb hover_enabled=\u00bb0″ header_3_font_size_tablet=\u00bb\u00bb header_3_font_size_phone=\u00bb20px\u00bb header_3_font_size_last_edited=\u00bbon|desktop\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0″]<\/p>\n The Chinese OTC and Rx market is one of the largest in the world and has a long and unique history. Healthcare is one of the three biggest economic pillars in China, along with education and housing. Reforming the healthcare system to make it more affordable has been a major priority of the Chinese government.<\/span><\/i><\/p>\n Progressive medical technologies and traditional medicine \u201cget along\u201d perfectly well.<\/span><\/p>\n The Chinese say: \u201c<\/span>A person who starts treatment after becoming sick is like a commander who begins to prepare a weapon when a battle has already started<\/b>.\u201d The comparison with a battle is not just an analogy. Traditional Chinese medicine treats disease as a fight which is better not to start at all.<\/span><\/p>\n During the reign of Emperor Qin Shi Huang (259-210 BC), all books on philosophy in China were burned on his order. <\/span>Only encyclopedic treatises with medical themes were retained<\/b>. Since then the attitude towards health and medicine in China has not changed. Even nowadays the <\/span>government is highly aware of the crucial importance of the Ministry of Health<\/b>.<\/span><\/p>\n Interest in ancient medical practices in China was revived in the mid-1950s. Surprisingly, this coincided with the beginning of the implementation of western medicine (adopted in most countries of the world) in China. This period can be considered the beginning of the bifurcation of Chinese medicine, the moment when its history divided and took two paths, very different in methods but ever so close in aims. Medicine in China is like a<\/span> two-headed dragon<\/b>: one of its heads is <\/span>traditional<\/b>, the other is <\/span>modern<\/b>; the body of the dragon represents a single desire, a single purpose\u2014to cure a patient. Today the Chinese healthcare system is recognized as containing a mixture of various treatment options for patients: from medical supplies to herbs, from surgery to acupuncture. Methods and approaches to treating a patient depend primarily on the disease and the individual\u2019s preferences.<\/span><\/p>\n From ancient times to nowadays there have been many different practices, and billions of people have been cured, but one thing remains constant: a great deal of attention has been and continues to be paid to medicine and its development.<\/span><\/p>\n <\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb0px|||||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bb#001389″ global_colors_info=\u00bb{}\u00bb]<\/p>\n Just as a house cannot stand without a strong foundation, so it is impossible for the health care system of a country to thrive without the development of a strong pharmaceutical sector. Three of these foundations are listed below:<\/span><\/p>\n At the moment, the Chinese Pharma industry<\/span> owns the<\/b> largest production resources on the planet<\/b>. China\u2019s self-medication and Rx industry mainly produces synthetic chemicals and drugs, prepared Chinese medicines, medical devices and machinery. Synthetic drug manufacturing is the largest component in China\u2019s consumer healthcare and Rx industry.\u00a0<\/span><\/p>\n The cosmetics sector on the Chinese mainland has been growing at a fast pace in recent years. The retail sales value of cosmetics in China rose to $52.3 billion in 2020, and is expected to reach <\/span>125 billion USD by 2035<\/b>, making it the world\u2019s second-largest beauty and personal care product market after the United States.<\/span><\/p>\n Mergers and acquisitions activity in China is especially dynamic (domestically and from a cross-border perspective). China and India are the <\/span>most active M&A players in the geographic region<\/b>.<\/span><\/p>\n China\u2019s over-the-counter market is also growing fast and has become one of the largest consumer healthcare markets in the world. Although OTC drugs only account for a minority of the Chinese pharmaceutical market, sales of these products are growing in increasing proportion to sales of prescription drugs. <\/span>The OTC Market should reach USD <\/b>248 billion <\/b>ex-factory <\/b>in 2035<\/b>.\u00a0<\/b><\/p>\n Currently, more stringent requirements for OTC and pharma companies in China have been put in place to minimize environmental violations. The 2011 five-year plan was introduced to strengthen measures ensuring product safety. The plan requires that production of synthetic drugs and drugs of biological origin occur in accordance with international standards and introduce new standards for quality control for medical products. <\/span>The 14th five-year plan (2021-2026)<\/b> will focus on modernizing the supply chain, as well as improving the products\u2019 quality. All of those changes aim at further developing the OTC and pharma market and put themselves on the map of the international consumer health and pharma market.\u00a0<\/span><\/p>\n <\/p>\n CPC expertise extends to the healthcare Industry in China and all over the world. All our multicultural experts possess extensive experience and have no fewer than <\/span>20 years in the global healthcare industry and emerging markets<\/b>, including China. We provide our clients with a wide range of Pharma and Healthcare Consulting Services focusing on Consumer Healthcare, Pharma Rx, Derma, Medical Devices, Food Supplements, FMCG and Wholesale. <\/span>We bring a global understanding of industry opportunities and challenges to every client, every time.<\/span><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ admin_label=\u00bbExpert Knowledge\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb min_height=\u00bb609.2px\u00bb custom_margin=\u00bb5px||-121px|||\u00bb custom_padding=\u00bb0px|||||\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row admin_label=\u00bbRow\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb min_height=\u00bb45px\u00bb custom_padding=\u00bb||0px|||\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n <\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_2,1_2″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_icon font_icon=\u00bb||divi||400″ icon_color=\u00bb#001389″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_icon][et_pb_text _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n OTC and pharma market size, ex-factory<\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_icon font_icon=\u00bb||divi||400″ icon_color=\u00bb#001389″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_icon][et_pb_text _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n OTC and pharma market growth<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ admin_label=\u00bbNumber Counter\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb background_color=\u00bb#EEEEEE\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_3,1_3,1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_number_counter title=\u00bbTotal population \u00bb number=\u00bb1 397 897 720 \u00bb percent_sign=\u00bboff\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb number_text_color=\u00bb#0B0B7A\u00bb number_font_size=\u00bb57px\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_number_counter title=\u00bbMale\/Female \u00bb number=\u00bb1.06″ percent_sign=\u00bboff\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb number_text_color=\u00bb#0B0B7A\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_number_counter title=\u00bbPopulation growth \u00bb number=\u00bb0.26%\u00bb percent_sign=\u00bboff\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb number_text_color=\u00bb#0B0B7A\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_number_counter][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_3,1_3,1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_number_counter title=\u00bbBirth rate\u00bb number=\u00bb11.3\/1000″ percent_sign=\u00bboff\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb number_text_color=\u00bb#0B0B7A\u00bb number_font_size=\u00bb72px\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_number_counter title=\u00bbMortality rate \u00bb number=\u00bb8.26\/1000″ percent_sign=\u00bboff\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb number_text_color=\u00bb#0B0B7A\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_number_counter title=\u00bbLife expectancy\u00bb number=\u00bb76.31 years\u00bb percent_sign=\u00bboff\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb number_text_color=\u00bb#0B0B7A\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_number_counter][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_cta title=\u00bbInterested in this market?\u00bb button_url=\u00bbhttps:\/\/www.chameleon-pharma.com\/about\/contacts\/\u00bb button_text=\u00bbClick Here\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb background_color=\u00bb#0B0B7A\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n <\/p>\n We are ready to support you in\u00a0Strategy, Marketing, Systematic International Company Partner Identification, Commercial Due Diligence, Business Development, Acquisition Search, Regulatory\u00a0projects,\u00a0and more in order to ensure your growth.<\/p>\n<\/div>\n<\/div>\n [\/et_pb_cta][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" China has estab\u00adlished an impres\u00adsive Health\u00adcare indus\u00adtry struc\u00adture, becom\u00ading one of the largest OTC and Pharma pro\u00adduc\u00aders in the world. The Chinese OTC and Pharma mar\u00adket has grown rapidly over the past ten years in the wake of the country\u2019s economic growth\u2014this is the main draw for Pharma investors with their sights set on China. […]<\/p>\n","protected":false},"author":7,"featured_media":0,"parent":8782,"menu_order":46,"comment_status":"open","ping_status":"open","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"[caption id=\"attachment_1351\" align=\"alignleft\" width=\"345\"]CPC Press Releases on China:<\/strong><\/h3>\n
China\u00a0<\/span><\/h1>\n
China: a traditional yet modern Rx and OTC market\u00a0<\/strong><\/h2>\n
Origins of Chinese Medicine<\/b><\/h3>\n
China OTC and pharma market\u00a0<\/b><\/h3>\n
\n
<\/span>The rate of China\u2019s economic growth<\/span> attracts foreign investments<\/b> in all sectors and particularly in the pharmaceutical industry. China reports that it increases its flow of money annually. By making use of Western experience, technology, cheap labor and financial resources, the Chinese have managed time to create an unbreakable ecosystem around their healthcare system within a short time period.<\/span><\/li>\n
<\/span>Huge annual <\/span>government subsidies<\/b> aimed at stimulating the growth of the medical market play an important role in the success of the consumer healthcare and prescription medicine market in China. For this reason, many training sessions for medical personnel are held annually, and advanced and innovative medical equipment for diagnostics and laboratory studies are produced.<\/span><\/li>\n
<\/span>In 2009 the Communist Party of China adopted a <\/span>program for the development of the pharmaceutical industry<\/b> in the country through 2020 called \u201cOpinions of the CPC Central Committee and the State Council on Deepening the Health Care System Reform\u201d. The program is funded with a budget of 123 billion dollars. Grants are distributed among exporters of pharmaceutical products, educational institutions and developers of pharmaceutical equipment.<\/span><\/li>\n<\/ol>\nThe China consumer health and pharma market hosts the largest production resources on the planet<\/b><\/h3>\n
China\u2019s cosmetics sector<\/b><\/h3>\n
M & A<\/b><\/h3>\n
OTC market<\/b><\/h3>\n
Trying to become better<\/b><\/h3>\n
Our Added Value<\/b><\/h3>\n
The Chinese OTC and pharma market in 2035<\/h2>\n
USD 248,2 billion<\/b><\/h3>\n
7-9%<\/b><\/h3>\n
China in numbers<\/h2>\n
<\/a> China-7571 - Sun and Moon Towers<\/a> von Dennis Jarvis <\/a> unter CC<\/a>[\/caption]\r\n\r\nChina has estab\u00adlished an impres\u00adsive Health\u00adcare indus\u00adtry struc\u00adture, becom\u00ading one of the largest OTC and Pharma pro\u00adduc\u00aders in the world.<\/strong> The Chinese OTC and Pharma mar\u00adket has grown rapidly over the past ten years in the wake of the country\u2019s economic growth\u2014this is the main draw for Pharma investors with their sights set on China.\r\n\r\nWith a total mar\u00adket value of US $82.2 billion, the Chi\u00adnese phar\u00adma\u00adceu\u00adti\u00adcal mar\u00adket is dom\u00adi\u00adnated by orig\u00adi\u00adnal pre\u00adscrip\u00adtion drugs.\r\n\r\nChina has a regional mar\u00adket dis\u00adtri\u00adb\u00adu\u00adtion sys\u00adtem, and its main cus\u00adtomers are hos\u00adpi\u00adtals (56%), phar\u00adma\u00adcies (24%) and local health cen\u00adtres (20%). Domes\u00adtic demand for tra\u00addi\u00adtional Chi\u00adnese med\u00adi\u00adcines has fallen in recent years, with ris\u00ading levels of edu\u00adca\u00adtion and fre\u00adquency of chronic dis\u00adease. The \u2018busy lifestyle\u2019 is shift\u00ading the population\u2019s pref\u00ader\u00adence from herbal supplements to chem\u00adi\u00adcal drugs, but these traditional med\u00adica\u00adtions still occupy a sig\u00adnif\u00adi\u00adcant place in the OTC mar\u00adket. Cold and flu med\u00adi\u00adcines account for the high\u00adest demand in the OTC seg\u00adment, while dia\u00adbetes, hyper\u00adten\u00adsion and heart dis\u00adease drugs drive the demand in the pre\u00adscrip\u00adtion drugs seg\u00adment.\r\n\r\nImported phar\u00adma\u00adceu\u00adti\u00adcals for human use must have already obtained mar\u00adket approval in the coun\u00adtry where they are manufactured and must undergo clin\u00adi\u00adcal test\u00ading and registration in China.\r\n\r\nIn terms of cur\u00adrent dis\u00adtri\u00adb\u00adu\u00adtion issues, hos\u00adpi\u00adtals remain the dom\u00adi\u00adnant sales chan\u00adnel for phar\u00adma\u00adceu\u00adti\u00adcal drugs, account\u00ading for 70%, while retail phar\u00adma\u00adcies com\u00adprise the remain\u00adder. There are an esti\u00admated 360,000 drug retail\u00aders in urban China, with around 2,000 retail phar\u00admacy chains that oper\u00adate 120,000 stores; two of every three retail phar\u00adma\u00adcies are sole traders.\r\n\r\nFour pre\u00advail\u00ading fac\u00adtors have con\u00adtributed to the chang\u00ading land\u00adscape of the phar\u00adma\u00adceu\u00adti\u00adcal mar\u00adket in China, mak\u00ading it the region to watch: urban\u00adi\u00adsa\u00adtion, an age\u00ading pop\u00adu\u00adlation, a lack of pri\u00admary care and a lack of pri\u00advate insur\u00adance.\r\n\r\nCur\u00adrently, how\u00adever, the Chi\u00adnese phar\u00adma\u00adceu\u00adti\u00adcal indus\u00adtry is focus\u00ading on generic prod\u00aducts. There is a great need for inno\u00adv\u00ada\u00adtive and pro\u00adpri\u00adetary prod\u00aducts in China that\u00a0will address the country\u2019s vast med\u00adical needs.\r\n\r\n\r\n\r\n\r\n\r\n\r\nCPC Press Releases on China:<\/strong><\/h3>\r\n